Comparison of Clinical Effects Between Rosiglitazone and Pioglitazone in the Treatment of Type 2 Diabetes of Eldly Patients

顾芹,陈芳,蒋翠萍,孙皎
DOI: https://doi.org/10.3969/j.issn.1007-4406.2008.05.001
2008-01-01
Abstract:AIM To compare the clinical effects of rosiglitatine with pioglitazone in the treatment of type 2 diabetic patients.METHODS Sixty-four patients who had been treated with food control,exercise and fixed oral anti-dia-betic drugs for one month,but their fasting plasma glucose level was still over 7 rranol·L-1.They were randomized divided into two groups.One was added with rosiglitazone,the other was added with pioglitazone.All of them were treated for 12 weeks.RESULTS After treatment for 12 weeks,①patient's fasting plasma glucose,postprandial plasma glucose,HbA1c and insulin resistance index were significant decreased in both groups;②triglyceride and total cholesterol were decreased in pioglitazone group(P<0.05),but those in rosiglitagone group were no significant reduction(P>0.05);③high density lipoprotein-cholesterol was elevated in both groups(P<0.05).CONCLUSION Rosiglitazone or pioglita zone can be used to control blood glucose,but pioglitazone shows more efficiency on triglyceride control.
What problem does this paper attempt to address?